News

PipelineReview.com10h
Early data suggest Roche’s NXT007 may have the potential to provide haemostatic normalisation in people with haemophilia A
BASEL, Switzerland I June 23, 2025 I Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today positive phase I/II data on NXT007 in people with haemophilia A, ...
PipelineReview.com9h
CagriSema 2.4 mg / 2.4 mg demonstrated 22.7% mean weight reduction in adults with overweight or obesity in REDEFINE 1, published in NEJM
PLAINSBORO, NJ, USA I June 22, 2025 I Today, The New England Journal of Medicine (NEJM) published results from Novo Nordisk's phase 3 REDEFINE 1 trial ...
PipelineReview.com9h
Gan & Lee Pharmaceuticals Presented Multiple Results in Novel Diabetes Therapies at the American Diabetes Association’s 85th Scientific Sessions
BEIJING, China and BRIDGEWATER, NJ, USA I June 21, 2025 I Gan & Lee Pharmaceuticals (Gan & Lee, stock code: 603087.SH) announced that the ...
PipelineReview.com10h
Harbour BioMed Enters Global Strategic Collaboration with Otsuka to Advance BCMAxCD3 Bispecific T-Cell Engagers
CAMBRIDGE, MA, USA; ROTTERDAM, The Netherlands and SHANGHAI, China I June 22, 2025 I Harbour BioMed (HKEX: 02142), a global biopharmaceutical company ...